Descriptive epidemiology of cholangiocarcinoma in Italy

Digestive and Liver Disease

Volumn 42, Issue 7, 2010, Pages 490-495

  Alvaro, Domenico ^a   Crocetti, Emanuele ^b   Ferretti, Stefano ^c   Bragazzi, Maria Consiglia ^a   Capocaccia, Riccardo ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Tuscany Cancer Registry   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cholangiocarcinoma; Epidemiology; Incidence; Italy; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER MORTALITY; FEMALE; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CHILD; CHILD, PRESCHOOL; CHOLANGIOCARCINOMA; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77955550585     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.10.009     Document Type: Article

References (32)

1. Blechacz B., Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008, 48:308-321.
2. Blechacz B.R., Gores G.J. Cholangiocarcinoma. Clin Liver Dis 2008, 12:131-150.
3. Khan S.A., Miras A., Pelling M., et al. Cholangiocarcinoma and its management. Gut 2007, 56:1755-1756.
4. Patel T., Singh P. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol 2007, 23:317-323.
5. Yachimski P., Pratt D.S. Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol 2008, 42:178-190.
6. Alvaro D., Mancino M.G. New insights on the molecular and cell biology of human cholangiopathies. Mol Aspects Med 2008, 29:50-57.
7. Alvaro D., Mancino M.G., Glaser S., et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 2007, 132:415-431.
8. Boberg K.M., Bergquist A., Mitchell S., et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002, 37:1205-1211.
9. Burak K., Angulo P., Pasha T.M., et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004, 99:523-526.
10. Kaczynski J., Hansson G., Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma-a study of 51 cases from a low-endemicity area. Acta Oncol 1998, 37:77-83.
11. Pardi D.S. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124:889-893.
12. Stiehl A. Development of dominant bile duct stenoses in patient with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002, 36:151-156.
13. Olsson R., Boberg K.M., de Muckadell O.S., et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized controlled study. Gastroenterology 2005, 129:1464-1472.
14. Brandsaeter B., Isoniemi H., Broomé U., et al. Liver transplantation for primary slerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004, 40:815-822.
15. Parkin D.M., Srivatanakul P., Khlat M., et al. Liver cancer in Thailand. I. A case control study of cholangicarcinoma. Int J Cancer 1991, 48:323-328.
16. Hansel D.E., Rahman A., Hidalgo M., et al. Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol 2003, 163:217-229.
17. Obama K., Ura K., Li M., et al. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 2005, 41:1339-1348.
18. Jinawath N., Chamgramol Y., Furukawa Y., et al. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. J Hepatol 2006, 44:1025-1038.
19. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001, 33:1353-1357.
20. McGlynn K.A., Tarone R.E., El-Serag H.B. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006, 15:1198-1203.
21. Welzel T.M., McGlynn K.A., Hsing A.W., et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006, 98:873-875.
22. Shaib Y.H., Davila J.A., McGlynn K., et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol 2004, 40:472-477.
23. Wood R., Brewster D.H., Fraser L.A., et al. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer 2003, 39:2087-2092.
24. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002, 3:10.
25. West J., Wood H., Logan R.F., et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006, 94:1751-1758.
26. http://www.rarecare.eu/.
27. Jepsen P., Vilstrup H., Tarone R.E., et al. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst 2007, 99:895-897.
28. Alvaro D., Macarri G., Mancino M.G., et al. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Ann Intern Med 2007, 147:451-459.
29. Alvaro D. Serum and bile biomarkers for cholangiocarcinoma. Curr Opin Gastroenterol 2009, 25:279-284.
30. El-Serag H.B., Engels E.A., Landgren O., et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009, 49:116-123.
31. Lee T.Y., Lee S.S., Jung S.W., et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 2008, 103:1716-1720.
32. Höblinger A., Lammert F. Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers. Curr Opin Gastroenterol 2008, 24:363-371.